ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/06/11 | 2,063 | 2,078 | 1,975 | 1,978 | -108 | -5.2% | 5,028,500 |
2019/06/10 | 2,047 | 2,239 | 2,024 | 2,086 | +72 | +3.6% | 10,143,100 |
2019/06/07 | 1,979 | 2,015 | 1,936 | 2,014 | +40 | +2% | 2,630,300 |
2019/06/06 | 2,054 | 2,070 | 1,909 | 1,974 | -69 | -3.4% | 4,863,300 |
2019/06/05 | 2,095 | 2,134 | 2,015 | 2,043 | +22 | +1.1% | 4,941,100 |
2019/06/04 | 2,028 | 2,083 | 2,009 | 2,021 | +13 | +0.6% | 3,371,200 |
2019/06/03 | 1,962 | 2,054 | 1,960 | 2,008 | -4 | -0.2% | 4,257,300 |
2019/05/31 | 2,015 | 2,114 | 1,984 | 2,012 | -71 | -3.4% | 8,224,500 |
2019/05/30 | 2,210 | 2,238 | 2,041 | 2,083 | -151 | -6.8% | 7,607,500 |
2019/05/29 | 2,245 | 2,264 | 2,165 | 2,234 | -61 | -2.7% | 6,814,900 |
2019/05/28 | 2,047 | 2,296 | 2,035 | 2,295 | +278 | +13.8% | 14,092,100 |
2019/05/27 | 2,030 | 2,058 | 1,977 | 2,017 | ±0 | ±0% | 4,234,000 |
2019/05/24 | 2,055 | 2,070 | 1,920 | 2,017 | +12 | +0.6% | 11,276,800 |
2019/05/23 | 1,850 | 2,149 | 1,845 | 2,005 | +218 | +12.2% | 20,540,400 |
2019/05/22 | 1,700 | 1,834 | 1,668 | 1,787 | +130 | +7.8% | 7,808,500 |
2019/05/21 | 1,661 | 1,687 | 1,591 | 1,657 | -5 | -0.3% | 2,921,700 |
2019/05/20 | 1,675 | 1,724 | 1,632 | 1,662 | +2 | +0.1% | 3,433,300 |
2019/05/17 | 1,594 | 1,680 | 1,587 | 1,660 | +100 | +6.4% | 4,654,000 |
2019/05/16 | 1,505 | 1,624 | 1,488 | 1,560 | +58 | +3.9% | 5,431,500 |
2019/05/15 | 1,643 | 1,743 | 1,491 | 1,502 | +8 | +0.5% | 10,756,700 |
2019/05/14 | 1,403 | 1,497 | 1,401 | 1,494 | +29 | +2% | 1,406,700 |
2019/05/13 | 1,486 | 1,511 | 1,429 | 1,465 | -21 | -1.4% | 1,363,600 |
2019/05/10 | 1,465 | 1,513 | 1,463 | 1,486 | +21 | +1.4% | 1,255,500 |
2019/05/09 | 1,558 | 1,561 | 1,447 | 1,465 | -66 | -4.3% | 1,448,000 |
2019/05/08 | 1,530 | 1,560 | 1,502 | 1,531 | -26 | -1.7% | 1,262,900 |
2019/05/07 | 1,456 | 1,567 | 1,445 | 1,557 | +99 | +6.8% | 1,863,200 |
2019/04/26 | 1,457 | 1,489 | 1,427 | 1,458 | -10 | -0.7% | 1,271,800 |
2019/04/25 | 1,422 | 1,476 | 1,421 | 1,468 | +31 | +2.2% | 1,235,200 |
2019/04/24 | 1,417 | 1,455 | 1,412 | 1,437 | +20 | +1.4% | 1,094,500 |
2019/04/23 | 1,380 | 1,427 | 1,373 | 1,417 | +28 | +2% | 1,243,200 |
2019/04/22 | 1,410 | 1,420 | 1,372 | 1,389 | -36 | -2.5% | 1,444,600 |
2019/04/19 | 1,389 | 1,429 | 1,383 | 1,425 | +40 | +2.9% | 1,453,500 |
2019/04/18 | 1,459 | 1,469 | 1,383 | 1,385 | -59 | -4.1% | 2,085,900 |
2019/04/17 | 1,424 | 1,456 | 1,395 | 1,444 | +4 | +0.3% | 1,851,500 |
2019/04/16 | 1,446 | 1,500 | 1,435 | 1,440 | -19 | -1.3% | 1,939,100 |
2019/04/15 | 1,429 | 1,485 | 1,415 | 1,459 | +30 | +2.1% | 1,856,000 |
2019/04/12 | 1,528 | 1,537 | 1,422 | 1,429 | -99 | -6.5% | 3,138,600 |
2019/04/11 | 1,631 | 1,634 | 1,400 | 1,528 | -103 | -6.3% | 5,220,800 |
2019/04/10 | 1,620 | 1,654 | 1,612 | 1,631 | -19 | -1.2% | 1,784,600 |
2019/04/09 | 1,670 | 1,717 | 1,604 | 1,650 | +13 | +0.8% | 4,138,100 |
2019/04/08 | 1,615 | 1,654 | 1,597 | 1,637 | +44 | +2.8% | 3,169,000 |
2019/04/05 | 1,501 | 1,608 | 1,501 | 1,593 | +71 | +4.7% | 3,638,000 |
2019/04/04 | 1,502 | 1,590 | 1,491 | 1,522 | +41 | +2.8% | 4,278,200 |
2019/04/03 | 1,490 | 1,542 | 1,445 | 1,481 | +15 | +1% | 2,903,900 |
2019/04/02 | 1,591 | 1,635 | 1,426 | 1,466 | -83 | -5.4% | 5,929,000 |
2019/04/01 | 1,538 | 1,683 | 1,518 | 1,549 | +44 | +2.9% | 8,841,100 |
2019/03/29 | 1,510 | 1,520 | 1,462 | 1,505 | -1 | -0.1% | 3,334,900 |
2019/03/28 | 1,436 | 1,557 | 1,420 | 1,506 | +71 | +4.9% | 5,677,600 |
2019/03/27 | 1,399 | 1,536 | 1,375 | 1,435 | +49 | +3.5% | 6,507,600 |
2019/03/26 | 1,412 | 1,432 | 1,374 | 1,386 | -6 | -0.4% | 2,234,400 |
1301~
1350
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,400円 | +197.7% | - | 0.00% | 51.24倍 | 1.64倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 349,000円 | +3.0% | +27.5% | 2.29% | 22.09倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,700円 | +3.2% | +4.5% | 3.38% | 17.66倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム